Skip to main content

Jamie Lynn Todd

Associate Professor of Medicine
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Box 103002, MSRB II, Durham, NC 27710
Suite 2073, MSRB II, 106 Research Drive, Durham, NC 27710

Overview


I am a physician-scientist with clinical and research expertise in lung transplantation and advanced lung disease, in particular idiopathic pulmonary fibrosis (IPF). My research aims to advance scientific knowledge related to the clinical and genetic risk factors underlying the development of lung fibrosis including that occurring in chronic lung transplant rejection and diseases leading to transplant, such as IPF. I also have an interest in understanding how the airway epithelial response to injury impacts lung repair, fibrosis, and tissue immunity.

Current Appointments & Affiliations


Associate Professor of Medicine · 2023 - Present Medicine, Pulmonary, Allergy, and Critical Care Medicine, Medicine
Member in the Duke Clinical Research Institute · 2012 - Present Duke Clinical Research Institute, Institutes and Centers

Recent Publications


Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohort.

Journal Article J Heart Lung Transplant · June 2025 BACKGROUND: Basiliximab induction immunosuppression is increasingly employed in lung transplant recipients despite limited prospective evidence to support its use in this population. We sought to determine the relationship between basiliximab induction and ... Full text Link to item Cite

Evaluating the performance of a resampling approach for internally validating the association between a time-dependent binary indicator and time-to-event outcome.

Journal Article J Biopharm Stat · April 27, 2025 Identifying clinical or biological risk factors for disease plays a critical role in enabling earlier disease diagnosis, prognostic outcomes assessment, and may inform disease prevention or monitoring practices. One framework commonly examined is understan ... Full text Link to item Cite

Identification and validation of a threshold for early posttransplant bronchoalveolar fluid hyaluronan that distinguishes lung recipients at risk for chronic lung allograft dysfunction.

Journal Article J Heart Lung Transplant · March 2025 BACKGROUND: Few tools exist for the early identification of patients at risk for chronic lung allograft dysfunction (CLAD). We previously showed hyaluronan (HA), a matrix molecule that regulates lung inflammation and fibrosis, accumulates in bronchoalveola ... Full text Link to item Cite
View All Publications

Recent Grants


Multiscale Modeling of Influenza Neutralizing Antibody and Fc Effector Biology

ResearchCo Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2029

EFC17801_9085-0205 SANOFI Pro00113681

Clinical TrialPrincipal Investigator · Awarded by Sanofi US · 2024 - 2028

Lung Transplant Clinical Trial Network (LT-CTN)

ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2028

View All Grants

Education, Training & Certifications


University of Colorado, School of Medicine · 2005 M.D.